AKTS — AKTIS ONCOLOGY INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About AKTIS ONCOLOGY INC (AKTS)
AKTIS ONCOLOGY INC (AKTS) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by George Soros (Soros Fund Management), valued at $2M. Across recent filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in AKTS
How many top investors track AKTS
Only 2 tracked investors report this position.
AKTS Ownership Composition
How AKTIS ONCOLOGY INC is held across tracked investor types, based on reported 13F positions.
- Hedge Funds57.1%
- Other42.9%
Tracked investors reporting AKTS
- George SorosMar 31, 2026Soros Fund ManagementShares100KValue$1.8M% Portfolio0.02%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares75KValue$1.3M% Portfolio0.00%
Recent activity
- New$1.3MMay 15, 2026
- New$1.8MMay 15, 2026
Frequently asked questions
- How many institutional investors hold AKTS?
- 2 tracked institutional investors disclosed a position in AKTS (AKTIS ONCOLOGY INC) in their most recent 13F filing.
- Who is the largest institutional holder of AKTS?
- George Soros, Soros Fund Management, holds the largest disclosed position in AKTS, valued at $2M.
- Did institutional ownership of AKTS increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 fully exited AKTS.
- Where does this AKTS ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.